Primary cell strain derived from human non-small cell lung cancer as well as preparation method and application thereof

• Main Authors: FENG FENGLAN, LI JIN
• Format: Patent
• Language: Chinese; English
• Published: 30.06.2023
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; COMPOSITIONS THEREOF; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; CULTURE MEDIA; ENZYMOLOGY; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; PROCESSES OF PREPARING SUCH COMPOSITIONS; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPIRITS; VINEGAR; WINE

The invention discloses a primary cell strain derived from human non-small cell lung cancer as well as a preparation method and application thereof, the primary cell strain derived from human non-small cell lung cancer is named as NSCLC-009T, and the preservation number is GDMCC NO.63195. The invention further discloses a preparation method and application of the primary cell strain derived from human non-small cell lung cancer. The primary cell strain derived from the human non-small cell lung cancer can be used for constructing a high-invasion and high-metastasis lung cancer model, can be used for target research and pharmacological mechanism research of clinical drugs for treating the high-invasion and high-metastasis lung cancer, has important significance on development of the drugs for treating the high-invasion and high-metastasis lung cancer, has high scientific research and production application values, and has wide application prospects. And good scientific research, economic and social benefits ca